NP Medical News about diabetes; glycaemic control

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes
Evidence-Based Medicine, 06/10/09

Sherifali D et al. - Diabetes is an extremely burdensome and costly chronic disease. It affects an estimated 4–6% of the world’s population, and its prevalence continues to rise. Diabetes is a major cause of blindness, end stage renal disease, and cardiovascular complications, all of which are preventable. Clinical practice guidelines for the management of diabetes emphasise the importance of optimal glycaemic control. Specifically, some clinical practice guidelines have suggested targeting a glycated haemoglobin (Hb) A1c concentration <=7%, or <=6% for those able to safely achieve it.

<< Previous
Review: head covering is associated with increased risk of sudden...

Next >>
In high-risk adolescents, cognitive-behavioural therapy reduced...